The lawsuit, filed by two former Medtronic employees, named 120 spine surgeons and 18 medical device distributors as defendants. The suit alleged that the defendants took a total of $8 million in consulting fees, advising "off-label" use of the Medtronic product, Infuse.
The federal judge ruled that the case did not constitute a whistle-blower suit and blocked an amended complaint by the defendant. Despite this ruling, a civil suit is still active in federal court.
Read about the dismissed Medtronic/spine surgeon lawsuit.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
